Programs
Employer Branding Student Partner
Regulatory Affairs Intern
Step 1: Apply for your favorite Internship
After you apply, you will receive an offer letter instantly. No queues, no uncertainty—just a quick start to your career journey.
Step 2: Submit Your Task(s)
You will be assigned weekly tasks to complete. Submit them on time to earn your certificate.
Step 3: Your task(s) will be evaluated
Your tasks will be evaluated by our team. You will receive feedback and suggestions for improvement.
Step 4: Receive your Certificate
Once you complete your tasks, you will receive a certificate of completion. This certificate will be a valuable addition to your resume.
About this Internship
Learn drug regulation in depth: the role of CDSCO and other regulators, how new drugs and generics are approved, the structure of a regulatory dossier, labelling requirements and how to respond to regulator queries. All tasks are research-based written assignments.
Tasks and Duties
Week 1: Comparative Regulatory Framework Report
Summary
Compare drug regulation in India, the USA and Europe.
Objective
Research the organisation and legal basis of the Central Drugs Standard Control Organisation in India, the United States Food and Drug Administration and the European Medicines Agency, explaining for each the governing law, the structure, the main divisions that deal with medicines, and the role of state or national authorities under them.
Prepare a detailed comparison table of the new drug approval process in the three regions covering the application type, the clinical data required, the review timelines, the fees, the role of expert committees, accelerated or priority pathways, and post-approval obligations, citing the official websites or guidance documents you used.
Explain the New Drugs and Clinical Trials Rules 2019 of India in detail, including the definition of a new drug, the different application forms, the timelines for approval of clinical trials, the deemed approval provisions, and the requirements for ethics committee registration and compensation for trial-related injury.
Write a one-page analysis of the strengths and weaknesses of the Indian regulatory system compared with the other two, referring to at least two published articles or expert reports, and propose three reforms, then submit the complete report as a 4-5 page Word or PDF document.
Week 2: Generic Drug Approval and Bioequivalence
Summary
Explain generic approval and design a bioequivalence study outline.
Objective
Explain the difference between an innovator drug, a generic drug and a branded generic, describe the concept of pharmaceutical equivalence, bioequivalence and therapeutic equivalence, and explain why a generic medicine does not need to repeat the full clinical trials of the original product, using the Hatch-Waxman Act and the Indian rules as references.
Describe step by step how a generic tablet is approved in India under the Drugs and Cosmetics Rules, including the licence from the state licensing authority, when CDSCO approval is required, when a bioequivalence study is mandatory for oral products, and the data a manufacturer must submit, and compare this with the Abbreviated New Drug Application process in the United States.
Design an outline of a bioequivalence study for a fictional generic 500 mg tablet, specifying the study design such as a two-period crossover, the number of healthy volunteers, the fasting or fed conditions, the sampling schedule, the pharmacokinetic parameters measured, and the acceptance criteria of 80 to 125 percent for the confidence interval, explaining each choice.
Conclude with a discussion of at least two hundred words on public concerns about generic quality in India, including the issue of not-of-standard-quality drugs found in CDSCO monthly alerts, and what regulators and companies are doing about it, then submit the complete work as a 4-5 page Word or PDF document.
Week 3: CTD Dossier Mapping Exercise
Summary
Map a complete regulatory dossier for a fictional generic product.
Objective
Study the structure of the Common Technical Document and explain the purpose and contents of each of the five modules, describing how Module 1 differs by region, what the quality overall summary and the clinical overview in Module 2 contain, and how Modules 3, 4 and 5 are organised into sections and subsections.
Choose a fictional generic product such as metformin 500 mg film-coated tablets and prepare a detailed mapping table that lists every section of Module 3 on quality, from drug substance characterisation through manufacturing process, control of excipients, specifications, analytical validation, batch analysis, container closure and stability, and describe in one or two lines the actual document that would be placed in each section.
For Modules 4 and 5, explain which non-clinical and clinical documents a generic application would normally include and which would be replaced by literature references or by the bioequivalence study report, and explain where the bioequivalence study report, the protocol, the ethics committee approval and the bioanalytical method validation would be filed.
Add a one-page section on the electronic CTD, describing its folder structure, the use of XML backbones, lifecycle management of submissions and the current status of eCTD adoption in India through the SUGAM portal, then submit the complete mapping exercise as a 4-5 page Word or PDF document.
Week 4: Label Audit and Deficiency Response
Summary
Audit a real label and draft a response to a regulator query.
Objective
Take any medicine strip, bottle or carton available at home, photograph or transcribe every piece of information printed on it, and research the complete list of labelling requirements under Rule 96 and Schedule D of the Drugs and Cosmetics Rules, including the recent requirements for barcodes and QR codes on top brands.
Prepare an audit checklist that lists each required element such as generic name prominence, manufacturing licence number, batch number, dates, MRP, storage conditions, schedule warnings and manufacturer address, marks whether the product complies, and for every gap or weakness explains the regulatory risk and the correction you would recommend, with a proposed corrected label text.
Write a fictional but realistic deficiency letter from a regulator to a manufacturer raising three queries about an application, for example a request for additional stability data, a question about the dissolution method and an objection to the proposed label, and then draft a formal point-by-point response from the company addressing each query with supporting arguments and a timeline.
Conclude with a one-page note on the career path, skills and professional certifications relevant to regulatory affairs in India and abroad, including the kind of work a fresher does in the first year, then submit the audit, the letters and the note as one 4-5 page Word or PDF document.
Launch Your Internship
Gain real-world skills, work on live projects and get an NSDC-affiliated certificate — absolutely free!